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Abstract
Following progressive reduction in confirmed cases of malaria from 2002 to 2007 (41,411 cases in 2002, 10,510
cases in 2003, 3,720 cases in 2004, 1,640 cases in 2005, 591 cases in 2006, and 198 cases in 2007). Sri Lanka entered
the pre-elimination stage of malaria in 2008. One case of indigenous malaria and four other cases of imported
malaria are highlighted here, as the only patients who presented to the Professorial Medical Unit, Colombo North
Teaching Hospital, Ragama, Sri Lanka over the past eight years, in contrast to treating several patients a week
about a decade ago. Therefore, at the eve of elimination of malaria from Sri Lanka, it is likely that the infection is
mostly encountered among travellers who return from endemic areas, or among the military who serve in un-
cleared areas of Northern Sri Lanka. They may act as potential sources of introducing malaria as until malaria
eradication is carried out. These cases highlight that change in the symptomatology, forgetfulness regarding
malaria as a cause of acute febrile illness and deterioration of the competency of microscopists as a consequence
of the low disease incidence, which are all likely to contribute to the delay in the diagnosis. The importance
regarding awareness of new malaria treatment regimens, treatment under direct observation, prompt notification
of suspected or diagnosed cases of malaria and avoiding blind use of anti-malarials are among the other
responsibilities expected of all clinicians who manage patients in countries reaching malaria elimination.
Background
The history of malaria in Sri Lanka dates back to the
ancient kingdoms. During the long documented history
of malaria in Sri Lanka several major epidemics were
experienced. The most devastating of these was the epi-
demic of 1934 - 1935 during which the districts in the
wet zone and the intermediate zone experienced high
incidence resulting in nearly 1.5 million patients and
80,000 deaths. In the last two decades, major epidemics
were encountered during the years 1987 and 1990/92.
Major natural determinants of malaria epidemics in Sri
L a n k ah a v eb e e nt h em o n s o o nr a i n se s p e c i a l l yt h e
North East monsoon, and also unusually dry weather
leading to pool formation in rivers and streams [1,2].
Following the introduction of dichloro-diphenyl-
trichloroethane (DDT) for mosquito vector control,
there was a record reduction in the cases of malaria,
with just seventeen cases in 1963 [2,3]. A similar sce-
nario was experienced in Crete after the introduction of
DDT in 1939 reduced malaria cases to undetectable
levels within five years, enabling discontinuation of
spraying DDT and declining malaria control activities
[4]. However, within a matter of few years there was a
resurgence of malaria in Crete due to the emergence of
DDT resistant vector species [4,5]. Sri Lanka also
experienced a resurgence of malaria in about five years.
A massive malaria epidemic was experienced during the
years 1967 - 1969 due to relaxation of surveillance.
Although the exact mechanism is not known, several
factors were thought to be contributory towards the fail-
ure. Persistence of several undetected foci of malaria
transmission, extensive intra-country population move-
ments particularly related to gem mining, lack of ade-
quate financial support from the authorities at the time
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have contributed to this [2]. Since then, malaria became
entrenched as a major illness in the island causing sev-
eral hundreds of thousands of cases each year and many
deaths.
The Anti-Malaria Campaign (AMC) in Sri Lanka
which continued on eradication principals for several
years was subsequently, reoriented as a control program
which included many elements of the earlier eradication
programme. During the past two decades or more, the
AMC had been functioning as a control programme
geared at achieving set objectives. Operationally, the
AMC had a centralized structure till 1989 and func-
tioned as a vertically run programme. However, in 1989
the programme was transformed into a decentralized
campaign, which was implemented by nine provincial
programs under the technical guidance of National
AMC Directorate. Due to efficient activities of AMC [2],
together with improvement in standards of housing in
populations in endemic regions and the use of mosquito
nets; especially those impregnated with insecticide, by
early 2000, there was a significant reduction in malaria
cases in the southern parts of the island. The confirmed
cases of malaria [Total (Vivax: Falciparum)] from 2002
to 2007 were; 41,411 cases in in 2002 (36,563:4,848),
10,510 cases in 2003-(9,237:1,273), 3,720 cases in 2004
(3,171:5,49), 1640 cases in 2005 (1,506:134), 591 cases in
2006 (564:27), 198 cases in 2007 (191:7) [6-8]. Mean-
while, malaria remained a problem in the northern and
eastern regions of the country due to the civil unrest.
However, despite the ongoing conflict, the AMC mana-
ged to deliver its services effectively, even in the deep
jungles, with the support of all district or provincial
malaria programmes and a few NGOs. In 2006 and
2007, the reported malaria cases in the country dropped
to 591 and 198 respectively [7,8]. Therefore, in 2008, Sri
Lanka entered the pre-elimination phase of malaria con-
trol, together with nine other countries: Mexico, Iran,
Azerbaijan, Georgia, Kyrgyzstan, Tajikistan, Turkey,
Uzbekistan and Democratic Republic of Korea [9].
Annual Parasite Incidence (API) (total number of posi-
tives cases per 1,000 risk population) for the Year 2002,
2008 and 2010 are presented in Figures 1, 2 and 3.
The following cases of malaria, all seen at the
Colombo North Teaching Hospital, Ragama, Sri Lanka
since 2003, illustrate the problems that are likely to be
encountered during attempts to eliminate malaria.
Case presentations
Case 1
In November 2007, a soldier, who was serving in an area
which were previously affected by the 30 years of civil
unrest in Jaffna, in northern Sri Lanka, presented with
fever and body aches after arriving home in the
C o l o m b os u b u r b s ;a na r e aw h i c hi sn o we n d e m i cf o r
dengue. He was suspected to be suffering from dengue
fever, but was detected to be having Plasmodium vivax
malaria on a routine blood film. He was successfully
treated with chloroquine anda1 4 - d a yc o u r s eo fp r i m a -
quine, ensuring clearance of malaria parasites by
repeated parasite counts (Table 1). The disease was noti-
fied immediately to the regional anti-malaria office
which enabled detection of a mini-outbreak of malaria
in Jaffna and among few of his colleagues who returned
to Hambantota, a southern city which was endemic for
malaria in the past. All these patients were rapidly
detected and treated, and it is possible that re-transmis-
sion of malaria was curtailed.
Case 2
In April 2008, an 18-year-old Sri Lankan male, who had
returned from Johannesburg South Africa three weeks
before, presented with fever, headache and confusion
over three days. He rapidly developed opisthotonus
(Table 1). At the very onset, he was suspected to be
Figure 1 Annual Parasite Incidence (API) (total number of
positives cases per 1000 risk population) for the Year 2002.
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Page 2 of 7having virus encephalitis. A blood film examined in a
p r i v a t el a b o r a t o r ys h o w e dP. vivax ring forms, which
was considered not compatible with his clinical illness.
However a thin blood smear reported by a specialist
detected Plasmodium malariae (Figure 4) and Plasmo-
dium falciparum mixed infection. The patient was suc-
cessfully treated with intravenous quinine followed by
doxycycline and Co-Artem
® as advised by the AMC.
Case 3
In December 2009, a 36-year-old Sri Lankan male
employed in Uganda presented with severe pallor and 5
cm firm splenomegaly (Table 1). He had returned to the
island about a month before due to feeling “lethargic”.H e
had repeatedly received short courses of the anti-malarial
“amodiaquine” while he was in Uganda for non-specific
aches and pains. His haemoglobin on admission was 5.5 g/
dl and blood tests were negative for malaria parasites and
malaria antigens. His blood picture showed basophilic
stippling of red blood cells and he was subsequently
detected having high serum lead levels confirming lead
poisoning. He was commenced on oral penicillamine and
received four units of packed-red-cell transfusion for anae-
mia. He was re-admitted with high fever after one month
and had severe pancytopaenia and was suspected to have
penicillamine toxicity. He was commenced on intravenous
antibiotics, but did not show clinical improvement over
the next few days. A repeat blood film showed P.
Figure 2 Annual Parasite Incidence (API) (total number of positives cases per 1000 risk population) for the Year 2008.
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Page 3 of 7falciparum ring forms (Figure 5) and P. falciparum anti-
gen was positive. He was successfully treated with i.v. qui-
nine followed by Co-Artem
®.
Cases 4 and 5
In September - October 2010, two Sri Lankan patients
both who returned home from Kolkata India presented
with high fever and severe body aches for four days
(Table 1). Investigations revealed progressive lowering of
platelets counts and rising hepatic enzymes, suggesting
dengue fever. Dengue and Leptospira antibodies were
negative. They were detected to have P. vivax malaria
on routine blood films and responded to anti-malarials
chloroquine followed by 14-day primaquine.
Consent
Consent was obtained from all relevant patients to
include their clinical details.
Ethical permission
Ethical permission to publish clinical details of patient
was obtained from the Ethics
Review committee, Faculty of Medicine, University of
Kelaniya, Sri Lanka
Discussion
The only five cases of malaria who presented to our unit
since 2003 are presented here. None of them had past
history of malaria. They were living within 25 km of the
hospital (Figure 3). The first case was unexpected in
southern Sri Lanka which is now considered non-ende-
mic for malaria. The patient was diagnosed to have
m a l a r i ao n l ya c c i d e n t l ya sm a l a r i ai sn o tc o n s i d e r e da
common cause of short duration febrile illness in these
areas. The other cases were imported malaria with vary-
ing degrees of severity and posing diagnostic dilemmas
due to the considerable time interval between return to
Sri Lanka and clinical presentation, their clinical presen-
tations suggesting an alternative diagnosis or due to
erroneous interpretation of blood films.
Occurrence of malaria in most southern parts of the
country is very rare during the last several years. There-
fore, clinicians practicing in these areas have almost for-
gotten it as a causative agent for short duration febrile
illness. However, they should be aware of the possibility
of unidentified asymptomatic low-grade parasitaemia or
occurrence of clinical P. vivax malaria due to relapse
that may contribute to individual cases or mini-out-
breaks until malaria eradication is achieved. Although, a
recent study failed to demonstrate detectable antigenae-
mia within these populations, in order to promptly diag-
nose such patients and also to achieve the final objective
of elimination of malaria, continued surveillance,
prompt parasitological confirmation and strict avoidance
of blind treatment with anti-malarials is required
[10,11]. Furthermore, if malaria occurs following blood
transfusions, blood donors from endemic areas should
be re-checked to ensure that they are free from asymp-
tomatic malaria as they could function as potential
sources for future outbreaks in endemic areas. The indi-
viduals living within 1 km of an index case or a poten-
tial breeding site are known to be at risk of malaria [12].
Therefore, vigilance is needed for any febrile patient
who lives within this geographical boundary. Recent stu-
dies on anopheles breeding sites has demonstrated
breeding of major Anopheles vector species that trans-
mit malaria in brackish water collections in Sri Lanka
[13] making any geographical location a vulnerable site
for vector breeding.
Except for the first patient all the other four patients
had returned to the country from a malaria endemic
region and they presented from April 2008 - October
2010. They were the only patients with malaria who
were admitted to our medical unit from the beginning
of 2003 to end of 2010, compared to ten or more
patients with indigenous malaria admitted a month
Figure 3 Annual Parasite Incidence (API) (total number of
positives cases per 1000 risk population) for the Year 2010.
The star shows the location of Colombo North Teaching Hospital,
Ragama. All the patients were residing within 25 Km from the
hospital
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Case Age Sex Admitted Clinical Haematology Biochemistry MP Treatment country
visited
14 6
y
M November
2007
High intermittent
fever, Body aches,
vomiting, diarrhoea of
4 days, 2 cm
splenomegaly and
tender hepatomegaly
3c m
Hb-11 g/dL,
WBC-4.8 × 10
9/L
N-55%, Platelet
110 × 10
9/L
ALT-110 iu/L, AST-
140 iu/L
P. vivax Parasite
count 3760/μL
Chloroquine
Premaquine
None
21 8
y
M April 2008 High intermittent
fever, severe headache,
vomiting, 4 days;
progressed to
confusion, rigidity over
24 hours, 3 cm
hepatomegaly
Hb-10 g/dL,
WBC-5.6 × 10
9/L,
N-64%, Platelet
158 × 10
9/L
ALT-90 iu/L AST-58
iu/LB. Urea: 65 mg/
dL
P. malariae and P
falciparum
parasite count
26,000/μL
iv Quinine +
Doxycycline
+ Co artum
+
Premaquine
Johannesburg
South Africa
33 3
y
M1
st
admission:
December
2009
Shortness of breath on
exertion, lethargy for
one month, sever
pallor, 6 cm
Splenomegaly
Hb- 5.5 g/dL,
WBC 6.2 × 10
9/L,
Platelets-230 ×
10
9/L, Basophilic
stippling in red
cells
ALT- 56 iu/L, AST-110
iu/L, Serum Pb > 65
mg/dL
Malaria parasite
nil. Malaria Ag
negative
Penicilamine Uganda
M2
nd
admission:
January
2010
High intermittent
fever, sever pallor, ill
and toxic, 8 cm
Splenomegaly and 4
cm hepatomegaly
Hb-6.5 g/dL,
WBC-2.2 × 10
9/L,
Platelets-65 ×
10
9/L, Retic
count-5% Bone
marrow biopsy:
normal
SGOT-100 iu/l, SGPT-
248 iu/L S.Bilirubin-
normal S.Protein-5.1
g/dl, Alb-3.7 g/dl,
Glob-1.3 g/dl gGT-
69.2 iu/L PT & INR-
1.14
P.
falciparumParasite
count 3550/μL
Iv Quinine +
Co artum +
Premaquine
43 5
y
M September-
2010
High intermittent
fever, mild icterus,
body aches, headache,
vomiting, 2 cm
splenomegaly, 4 cm
hepatomegaly
Hb-10.5 g/dL,
WBC-2.8 × 10
9/L,
Platelets-45 ×
10
9/L,
ALT-430 iu/L, AST-
560 iu/L, S.Bil 3.4
mg/dl B. Urea: 98
mg/dL
P. vivax + ve
(serology for
Dengue
leptospira, Viral
hepatitis A, B, C, E
negative)
Chloroquine
+
Premaquine
Kolkata India
52 8
y
M October
2010
High intermittent
fever, mild icterus,
body aches, headache,
vomiting, 4 cm
splenomegaly, 3 cm
tender hepatomegaly
Hb-11.5 g/dL,
WBC-6.2 × 10
9/L,
Platelets-35 ×
10
9/L,
ALT-630 iu/L, AST-
1054 iu/L, Serum
Bilirubin 2.4 mg/dl B.
Urea: 45 mg/dL
Figure 4 Plasmodium malariae band form in patient 2. Figure 5 Plasmodium falciparum ring forms in patient 3.
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malaria incidence of seventeen cases were recorded and,
eleven out of the seventeen were considered imported
cases [3], today, the occurrence of malaria seems to be a
consequence of expanding travel outside the country.
Foreign employment and participation in long duration
training or study courses in malaria endemic areas and
UN missions by Sri Lankan security personnel account
for most cases of imported malaria. Although short
duration travel carries a low risk, such travel to malaria
endemic countries has resulted in infections. Pitfalls in
the diagnosis of imported malaria could occur due to
delayed symptoms, especially among those who return
after long stays in endemic countries as observed in the
2
nd and 3
rd cases; this could either be due to weaning of
immunity following absence of repeated exposure to
malaria after return [14,15], or suppression of a partially
resistant strain of P. falciparum to repeated doses of
amodiaquine given as prophylaxis or as part of treat-
ment in an endemic setting [16]. Altered symptomatol-
ogy, occurrence of more severe forms of illness due to
vivax malaria, liver and renal involvement, and reduction
in platelet counts [17-19] may lead to erroneous diag-
noses such as dengue fever or leptospirosis, as observed
in the 4
th and 5
th cases. Waning of skills and experience
of microscopists (2
nd and 3
th cases) due to the low inci-
dence of malaria may also contribute to a delay in diag-
nosis [20].
In the face of the problem of erroneous microscopic
diagnosis by technicians, it is mandatory that any sus-
pected or “diagnosed” case be re-confirmed by a specia-
list and/or by detecting antigens through rapid
diagnostic kits, before they are commenced on treat-
ment. Any doubts in the diagnosis should be clarified by
the WHO reference laboratory by genotyping.
Clinicians should adhere to treatments recommended
for the elimination phase and in the event of imported
malaria, they should liaise with the AMC or relevant
authorities for the most appropriate treatment for such
patients, as was done in case 2.
Conclusions
Sri Lanka entered the pre-elimination stage of malaria in
2008. Infection is mostly encountered among travellers
who return from endemic areas such as African coun-
tries and from India, or among military personnel ser-
ving in the northeast of the country. They may act as
potential sources of reintroducing malaria, as elimina-
tion of the vector is not feasible. The change in sympto-
matology, forgetfulness of malaria as a cause of acute
febrile illness and deterioration of the competence of
microscopists are all likelyt oc o n t r i b u t et oad e l a yi n
the diagnosis. Awareness of new treatment regimens,
treatment under direct observation and prompt
notification of suspected/diagnosed cases to the AMC
are the responsibility of all clinicians who manage
patients with malaria. Therefore, a good step-wise sur-
veillance programme to detect all malaria cases either
indigenous or imported, will help achieving the final
goal of eliminating malaria from Sri Lanka.
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